Announcements Trials

Browse Landscape

Phase

Phase 2 6 Phase 3 2 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 28 Leukemia, Myeloid, Acute 27 Precursor Cell Lymphoblastic Leukemia-Lymphoma 24 Leukemia 23 Lymphoma 22 Small Cell Lung Carcinoma 20 Burkitt Lymphoma 19 Lymphoma, Non-Hodgkin 18 Lung Neoplasms 13 Recurrence 12 Neuroblastoma 12 Lymphoma, Mantle-Cell 12 Leukemia, Lymphocytic, Chronic, B-Cell 12 Congenital Abnormalities 12 Myelodysplastic Syndromes 11 Lymphoma, Follicular 11 Brain Neoplasms 10 Hodgkin Disease 9 Carcinoma, Non-Small-Cell Lung 9 Lymphoma, Large-Cell, Immunoblastic 8 Lymphoma, B-Cell, Marginal Zone 8 Leukemia, Myeloid, Accelerated Phase 8 Leukemia, Monocytic, Acute 8 Leukemia, Megakaryoblastic, Acute 8 Leukemia, Erythroblastic, Acute 8 Blast Crisis 8 Sarcoma 7 Neoplasms 7 Myeloproliferative Disorders 7 Multiple Myeloma 7

Interventions

Cyclophosphamide 9 Topotecan 5 Temozolomide 5 Melphalan 5 Irinotecan 5 Busulfan 5 fludarabine 4 Granulocyte Colony-Stimulating Factor 4 Filgrastim 4 liposomal doxorubicin 3 fludarabine phosphate 3 cabozantinib 3 Vincristine 3 regorafenib 2 pegfilgrastim 2 Sirolimus 2 Doxorubicin 2 Bone Marrow Transplantation 2 trioctyl phosphine oxide 1 trifluridine tipiracil drug combination 1 thymoglobulin 1 talazoparib 1 selinexor 1 seclidemstat 1 racotumomab 1 poly ICLC 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 olaparib 1 niraparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Sarcoma, Ewing × Etoposide × Clear all

NCT07194044 2026-05-15

METTSEO

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Recruiting

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡